|
Older than the age of 65 | yes
|
|
according to gastric cancer guidelines diagnostic criteria of the national comprehensive cancer network (NCCN) in 2014, were diagnosed with stage II, III gastric cancer postoperative | yes
|
|
According to Nutritional Risk Screening 2002 (NRS 2002) of the European society of parenteral enteral nutrition, their global scoring were more than 3 points | |
|
normal hepatic and renal function before surgery | yes
|
|
hormone, immunopotentiator or immunosuppressor were not administered half a year before surgery | yes
|
|
Without radiotherapy, and chemotherapy preoperative | yes
|
|
moderate anemia, hemoglobin< 90 g/L | no
|
|
severe hypoalbuminemia, albumin< 25 g/L | no
|
|
with at least one disease as listed following | |
|
metabolic and allergic diseases,Such as total triglyeride>2.26mmol or total cholesterol>6.2mmol/L | no
|
|
overweight patients, BMI>28 | no
|
|
Special circumstances in the operation |
|
age | 66 years |
|
Body Mass Index | 20.4 |
|
albumin | 27 g/L |
|
preaalbumin | 238 mg/L |
|
transferrin | 1.79 g/L |
|
Alanine aminotransferase | 22 U/L |
|
Total bilirubin | 16 mmol/L |
|
CD3 | 63.9 % |
|
CD4 | 37.7 % |
|
CD8 | 27.7 % |
|
CD4/CD8 | 1.24 |
|
IgA | 1.08 % |
|
IgG | 6.5 % |
|
IgM | 0.55 % |
|
C-reactive protein | 12 mg/L |
|
Interleukin 6 | 3.3 pg/L |
|
albumin | g/L |
|
preaalbumin | mg/L |
|
transferrin | g/L |
|
alanine aminotransferase | U/L |
|
Total bilirubin | mmol/L |
|
CD3 | % |
|
CD4 | % |
|
CD8 | % |
|
CD4/CD8 |
|
|
IgA | g/L |
|
IgG | g/L |
|
IgM | g/L |
|
C-reactive protein | mg/L |
|
Interleukin 6 | pg/L |
|
albumin | 33 g/L |
|
preaalbumin | 218 mg/L |
|
transferrin | 1.32 g/L |
|
Alanine aminotransferase | 22 U/L |
|
Total bilirubin | 9 mmol/L |
|
CD3 | 57.4 % |
|
CD4 | 38.5 % |
|
CD8 | 18.6 % |
|
CD4/CD8 | 2.06 |
|
IgA | 1.08 g/L |
|
IgG | 2.03 g/L |
|
IgM | 0.7 g/L |
|
C-reactive protein | 90 mg/L |
|
Interleukin 6 | 71.3 pg/L |
|
albumin | 29 g/L |
|
preaalbumin | 199 mg/L |
|
transferrin | 1.55 g/L |
|
Alanine aminotransferase | 40 U/L |
|
Total bilirubin | 29 mmol/L |
|
CD3 | 48.1 % |
|
CD4 | 23.2 % |
|
CD8 | 28 % |
|
CD4/CD8 | 0.75 |
|
IgA | 0.14 g/L |
|
IgG | 7.3 g/L |
|
IgM | 0.57 g/L |
|
C-reactive protein | 5 mg/L |
|
Interleukin 6 | 17.1 pg/L |
|
infection | |
|
anastomotic leakage |
|
hospitalization costs | 42638 yuan |
|
hospital stays | 15 Day |




